ConductScience.org, home

Paper8097632

Clinical significance of P-glycoprotein in multidrug resistance malignancies.

Arceci RJ. Blood, 1993. Cited by 236 papers, by iCite.

Cite this record

ConductScience Library. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Papers, record 8097632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097632

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical significance of P-glycoprotein in multidrug resistance malignancies.
PubMed
Journal
Blood
PubMed
Year
1993
PubMed
Publication types
Editorial, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
236
iCite
Relative citation ratio, by iCite
6.61
iCite
Revised in PubMed
2021-02-16
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Arceci RJR J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug ResistanceMajor topic
Membrane GlycoproteinsMajor topic
NeoplasmsMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Adult
Animals
Antineoplastic Agents
Child
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA48162NCI NIH HHSUnited StatesR01CA048162PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00011414Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid TumorsBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in7902138Low incidence of activity of P-glycoprotein (P-170) in de novo acute lymphoblastic leukemia determined by a flow cytometric assay.https://conductscience.org/library/papers/7902138

Source PubMed

Download CSV of comments and corrections

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.

PMIDTitleJournalYearIn PapersSource
33198344Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer.Cancers (Basel)2020https://conductscience.org/library/papers/33198344PubMed
32581566Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review.Pharmgenomics Pers Med2020https://conductscience.org/library/papers/32581566PubMed
30579343Genetic and molecular origins of colorectal Cancer among the Iranians: an update.Diagn Pathol2018https://conductscience.org/library/papers/30579343PubMed
29948283Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid.Arch Dermatol Res2018https://conductscience.org/library/papers/29948283PubMed
28353592The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy: A meta-analysis.Medicine (Baltimore)2017https://conductscience.org/library/papers/28353592PubMed
27916761
CAN a P-gp modulator assist in the control of methotrexate concentrations in the rat brain? -inhibitory effects of rhodamine 123, a specific substrate for P-gp, on methotrexate excretion from the rat brain and its optimal route of administration.
J Vet Med Sci2017https://conductscience.org/library/papers/27916761PubMed
26486517
Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors.
Cancer Chemother Pharmacol2015https://conductscience.org/library/papers/26486517PubMed
26354214Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase.Indian J Med Res2015https://conductscience.org/library/papers/26354214PubMed
26222892N-(2-Hydroxypropyl)methacrylamide Copolymer-Drug Conjugates for Combination Chemotherapy of Acute Myeloid Leukemia.Macromol Biosci2016https://conductscience.org/library/papers/26222892PubMed
25947324Effect of cyclosporin on distribution of methotrexate into the brain of rats.J Vet Med Sci2015https://conductscience.org/library/papers/25947324PubMed
25378644Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.Sci Transl Med2014https://conductscience.org/library/papers/25378644PubMed
23762410An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells.PLoS One2013https://conductscience.org/library/papers/23762410PubMed
22038456Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia.J Appl Genet2012https://conductscience.org/library/papers/22038456PubMed
21380926The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line.Int J Hematol2011https://conductscience.org/library/papers/21380926PubMed
20528455Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Nanomedicine (Lond)2010https://conductscience.org/library/papers/20528455PubMed
20298675Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy.Biochem Pharmacol2010https://conductscience.org/library/papers/20298675PubMed
20209646Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.Pediatr Blood Cancer2010https://conductscience.org/library/papers/20209646PubMed
20147974Chronic myeloid leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 activity.Leukemia2010https://conductscience.org/library/papers/20147974PubMed
20127181Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population.Mol Biol Rep2011https://conductscience.org/library/papers/20127181PubMed
15239391Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease.Int J Hematol2004https://conductscience.org/library/papers/15239391PubMed

See all 36 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8097632

GET https://conductscience.org/api/papers/v1/8097632/cited_by?page=2